A history of hypertension was more common in CES than in ESUS (51.7% vs. 29.6%; p = 0.001), although the relative use of antihypertensive subclasses—including ACE inhibitors, ARBs, beta blockers, and calcium channel blockers—was comparable between groups. This evidence concerns the gene ACE and Hypertension.